National Association of Testing Authorities, Australia
Scope of Accreditation
ACT Pathology
Site
Canberra Hospital
Accreditation No.
2508
Site No.
2501
Date of Accreditation
28 Oct 1988
Address
Building 10, Canberra Hospital, 77 Yamba Drive
Garran, ACT 2605
Australia
Contact
Mr Matthew Auhl P: +61 (02) 51244004
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Anatomical Pathology
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical smear; Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Liquid based cytology specimens; Vaginal smears; Vault smears; Vulval smears | Cytological examination |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Bronchial lavage; Cerebrospinal fluid (CSF); Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples | |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Conjunctival smears; Nipple discharge | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsyFNA Attendance | Fine needle aspirates (FNA) | Cytological examination; Rapid onsite evaluation (ROSE); Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program | Liquid based cytology specimens from cervix; Liquid based cytology specimens from vaginal vault | Human papilloma virus (HPV); Cytological examination; Review and reporting of cervical cytological material |
| Human papilloma virus (HPV) | ||
| Self-collected vaginal swabs | Human papilloma virus (HPV) | |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopy | Gluteraldehyde tissue | Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Frozen tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue | Detection of antigenic targets - Various | |
| Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 2 mortuary |
| Anatomical pathology - Tissue pathology - Non-coronial autopsy services | Body; Body parts | Perinatal autopsy service and reporting |
Chemical Pathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Renal calculi | Albumin; Ammonium; Ammonium hydrogen urate; Apatite; Bilirubin; Brushite; Calcium; Calcium carbonate - Dahllite; Calcium oxalate dihydrate (weddelite); Carbonate; Cholesterol; Cysteine; Cystine; Hydrated calcium oxalate (whewellite); Hydroxylapatite (hydroxyapatite); Indinavir (drug induced calculi); Magnesium; Magnesium ammonium phosphate - Struvite; Oxalate; Phosphate; Quartz (silica); Silicon; Sodium urate; Sulfate; Urate; Uric acid; Whitlockite; Xanthine |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Alcohol |
| Urine | Amphetamines; Benzodiazepines; Cannabinoids; Cocaine; Methadone; Opiates | |
| Chemical pathology - Biogenic amines | Plasma | 3-Methoxytyramine; Metanephrine; Normetanephrine |
| Urine | 3-Methoxytyramine; 5-Hydroxyindoleacetic acid (5-HIAA); Catecholamines; Homovanillic acid (HVA); Metanephrine; Normetanephrine; Vanillylmandelic acid (VMA) | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin |
| Tacrolimus | ||
| Plasma; Serum | Clozapine; Norclozapine | |
| Amikacin; Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Paracetamol (acetaminophen); Pentobarbitone; Phenytoin (dilantin); Salicylate; Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | ||
| Methotrexate | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | Thyroglobulin |
| CA19-9 antigen (CA19-9); Human chorionic gonadotropin (hCG) | ||
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); Prostate specific antigen (PSA) - Free; α-Fetoprotein (AFP) | ||
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Adrenocorticotropic hormone (ACTH); C-peptide |
| Macroprolactin; Parathyroid hormone (PTH) | ||
| Renin | ||
| Dehydroepiandrosterone (DHEA); Sex hormone binding globulin (SHBG); Testosterone | ||
| Cortisol; Follicle stimulating hormone (FSH); Free androgen index (FAI); Insulin; Luteinising hormone (LH); Oestradiol; Progesterone; Prolactin | ||
| Aldosterone; Growth hormone; Insulin-like growth factor 1 (IGF-1, somatomedin C) | ||
| Urine | Cortisol | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Dynamic tests | Sweat | Sweat chloride |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Troponin I |
| N-Terminal-pro b-type natriuretic peptide (NT-proBNP) | ||
| Serum | Troponin T | |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Caeruloplasmin |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Albumin; Glucose; Lactate; Protein - Total |
| Plasma; Serum | Cholinesterase | |
| Alanine aminotransferase; Albumin; Alkaline phosphatase; Anion gap; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Corrected for albumin; Calcium - Total; Chloride; Cholesterol - LDL; Cholesterol - Non HDL; Cholesterol - Total; Cholinesterase; Creatine kinase; Creatinine; Globulin; Glomerular filtration rate; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Osmolality; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | ||
| Ammonia | ||
| Plasma; Serum; Urine | Osmolality | |
| Urine | Ketones | |
| Albumin; Calcium - Total; Chloride; Creatinine; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | ||
| pH | ||
| Chemical pathology - Investigation for folate deficiency | Blood | Red blood cell folate |
| Plasma; Serum | Folate | |
| Chemical pathology - Investigation of malabsorption | Faeces; Urine | Reducing substances |
| Chemical pathology - Investigation of porphyria | Urine | Porphobilinogen (PBG) |
| Chemical pathology - Iron studies | Plasma; Serum | Iron; Transferrin |
| Ferritin | ||
| Chemical pathology - Markers of bone metabolism | Plasma; Serum | Procollagen type 1 N-terminal propeptide (P1NP); β-Crosslaps (CTX) |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Calcium - Ionised (pH corrected); Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma; Serum | Homocysteine |
| Chemical pathology - Quantitation of vitamin B markers | Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | Cobalamin (vitamin B12) |
| Serum | 25-Hydroxyvitamin D | |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Serum | Copper |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-thyrotropin receptor antibodies (TSHR) |
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) | ||
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Delivery Suite
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium; Calcium - Ionised (pH corrected); Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Diabetes and Endocrinology Clinic
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Diagnostic Genomics
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Tissue pathology - Gene probes using paraffin fluorescence in situ hybridisation (FISH) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in situ hybridisation techniques | Blood; Bone marrow; Lymph nodes; Other tissues - Malignant; Other tissues - Non-malignant; Products of conception (POC); Smears; Tissues; Tumour imprints | Chromosomal rearrangement; Constitutional genetic abnormalities; Cytogenetic analysis and reporting; Detection of nucleic acid targets - Various; Pathogenic copy number changes |
| Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities | Blood; Bone marrow; Foetal tissue; Lymph nodes; Other body fluids; Other tissues - Malignant; Other tissues - Non-malignant; Products of conception (POC) | Aneuploidy detection for chromosomes; Chromosomal rearrangement; Cytogenetic analysis and reporting; Pathogenic copy number changes |
| Foetal tissue; Products of conception (POC) | Absence of heterozygosity; Aneuploidy detection for chromosomes; Cytogenetic analysis and reporting; Pathogenic copy number changes | |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Factor V Leiden; Prothrombin gene (G20210A) mutation; Prothrombin variant |
| Blood; Purified DNA | HLA-B27 | |
| Molecular genetics - DNA extraction | Blood; Bone marrow; Fibroblast cell pellets; Fresh tissue; Phosphate buffered mononuclear cells; Products of conception (POC); Skin biopsy; Tissues; Trephine | DNA storage for future analyses; Viable DNA for sequencing; Viable DNA for sequencing and other molecular assays |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood | Acute lymphoblastic leukaemia; Chronic myeloid leukaemia (CML); Qualitative detection of p210 positive BCR::ABL1 transcripts |
| Acute lymphoblastic leukaemia; Chronic myeloid leukaemia (CML); Quantitative calculation of p210 positive BCR::ABL1 transcripts | ||
| Formalin-fixed paraffin-embedded (FFPE) tissues | BRAF mutation analysis; EGFR mutation analysis; KRAS mutation analysis; Melanoma; Metastatic colorectal carcinoma; NRAS-BRAF mutation analysis; Non-small cell lung cancer and other tumours |
Emergency Department
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Gungalin Health Centre
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Haematology
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Examination of haemoglobin H (HbH) |
| Examination of haemoglobin H (HbH) | ||
| Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation | ||
| Haematology - Examination of blood films by special staining | Blood | Babesia spp. |
| Malaria | ||
| Heinz bodies | ||
| Blood; Bone marrow | Non-specific esterase | |
| Bone marrow | Iron | |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens; Detection and quantitation of foetal red cells |
| Detection and quantitation of foetal red cell antigens; Detection and quantitation of foetal red cells | ||
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean platelet volume (MPV); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes |
| Differential number; Morphology; Platelet count | ||
| Haematocrit (packed cell volume, PCV) | ||
| Haemopoietic progenitor cells | Leucocyte count (white blood cell count, WBCC) | |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Thromboelastometry | ||
| Blood; Plasma | Platelet aggregation; Platelet specific antibodies | |
| Plasma | Collagen binding activity; Heparin induced thrombocytopenia (HIT) - Confirmatory; Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | |
| Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Rivaroxaban; Anti-Xa activity; Anti-thrombin III; Factor II; Factor IX; Factor IX inhibitor; Factor V; Factor VII; Factor VIII; Factor VIII inhibitor; Factor VIIIc; Factor X; Factor XI; Factor XII; Fibrinogen; Fibrinogen degradation products; International normalised ratio (INR); Lupus anticoagulant; Protein C and protein S; Prothrombin time (PT); Thrombin time (TT) | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin fraction (S, C, D, E) - Quantitation; Other abnormal haemoglobins |
| Haematology - Investigation of haemolysis | Blood | Cold agglutinins |
| Haemoglobin (Hb) | ||
| Paroxysmal nocturnal haemoglobinuria (PNH) screen | ||
| Hereditary spherocytosis (eosoin-5-maleimide) | ||
| Plasma | Donath-Landsteiner antibody | |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Erythrocyte (RBC) sedimentation rate (ESR) | ||
| Plasma | Viscosity | |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen | Assessment of lymphoid cell populations; Assessment of myeloid cell populations |
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProduct received from AN 18824 SN 20972 | Blood; Haemopoietic progenitor cells | Enumeration of CD34+ cells |
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProduct received from AN 18824 SN 20972 | Haemopoietic progenitor cells | Processing; Storage (includes freezing/thawing) |
| Immunopathology - Tests of cellular immunity - Lymphocyte function tests | Blood; Bone marrow; Other body fluids | T-cell subsets; T-lymphocyte, B-lymphocyte and natural killer (TBNK) |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma; Serum | Infectious mononucleosis |
Haemodialysis
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Calcium - Ionised (pH corrected); Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Immunohaematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
| Other blood group systems; Rh phenotypes | ||
| Immunohaematology - Blood grouping | Blood; Cord blood | ABO; RhD |
| ABO; RhD | ||
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies | ||
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody titration |
| Other blood group antibodies; Red blood cell phenotyping | ||
| Other blood group antibodies; Red blood cell phenotyping | ||
| Antibody titration | ||
| Antibody elution | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
| Antibodies | ||
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
Immunopathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | β2-Microglobulin (B2M) |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Haptoglobins; α1-Antitrypsin |
| Tryptase | ||
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Plasma; Serum | Angiotensin converting enzyme (ACE) |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-glomerular basement membrane antibodies (anti-GBM) |
| Anti-neutrophil cytoplasmic antibodies (ANCA) | ||
| Anti-C1q antibodies | ||
| Anti-cyclic citrullinated peptide antibodies (CCP) | ||
| Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-smooth muscle antibodies (SMA) | ||
| Anti-myositis antibodies | ||
| Anti-F actin antibodies | ||
| Anti-liver antibodies | ||
| Anti-Crithidia luciliae antibodies; Anti-nuclear antibodies (ANA) | ||
| Anti-cardiolipin IgG antibodies (ACA); Anti-cardiolipin IgM antibodies (ACA); Anti-deamidated gliadin IgG antibodies; Anti-double stranded DNA antibodies (dsDNA); Anti-extractable nuclear antigen antibodies (ENA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase IgA antibodies (tTG); Anti-β2-glycoprotein-I IgG antibodies; Anti-β2-glycoprotein-I IgM antibodies | ||
| Rheumatoid factor | ||
| Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-endomysial IgA antibodies (EMA); Anti-intercellular cement substance IgG antibodies; Anti-skin basement membrane IgG antibodies | ||
| Anti-gastric parietal cell antibodies (GPC/PCA) | ||
| Anti-cardiolipin antibodies (ACA) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Penicilloyl G; Penicilloyl V |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Cat dander; Cat epithelium; Chicken feathers; Cow dander; Dog dander; Duck feathers; Goose feathers; Guinea pig epithelium; Hamster epithelium; Horse dander; Mouse epithelium; Mouse serum proteins; Mouse urine proteins; Rabbit epithelium; Rat epithelium; Turkey feathers |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg white |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Blue mussel; Codfish; Salmon; Shrimp; Tuna |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Avocado; Banana; Kiwi; Mango; Melon; Orange citrus; Papaya; Peach; Pineapple |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Brazil nut; Cashew nut; Hazelnut; Macadamia nut; Peanut; Pecan nut; Pistachio; Sesame seed; Soy bean; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Cocksfoot; Kentucky blue; Meadow fescue; Rye grass; Timothy grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | German cockroach |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Aspergillus fumigatus; Candida albicans; Cladosporium herbarum; Malassezia spp.; Penicillium chrysogenum (formerly Penicillium notatum); Pityrosporum orbiculare (Malassezia furfur); Setomelanomma rostrata (Helminthosporium halodes); Staphylococcus enterotoxins |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; House dust - Hollister-Stier |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Latex |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Box-elder; Elm; Eucalyptus; Melaleuca; Oak; Olive; Silver birch; Walnut; White pine; Willow salix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Honey bee venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Common ragweed; Lamb’s quarters; Mugwort; Plantain - English; Russian thistle |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF); Serum | Oligoclonal bands |
| Plasma | Cryofibrinogen | |
| Serum | Cryoglobulins | |
| Detection and quantitation of free kappa and free lambda light chains; Free kappa and free lambda light chains ratio | ||
| Albumin; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | ||
| Characterisation of cryoglobulins | ||
| Serum; Urine | Characterisation of paraproteins | |
| Urine | Detection of Bence Jones proteins | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Cerebrospinal fluid (CSF) | Total immunoglobulin G |
| Plasma; Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M | |
| Serum | Immunoglobulin G (IgG) subclasses | |
| Total immunoglobulin E |
Infectious Immunoassay
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Mycobacteriology - Tests for cell mediated immunity | Blood | Latent tuberculosis |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody |
| Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis C virus antibody (anti-HCV) | ||
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus viral capsid antigen IgM antibody; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Confirmatory; Hepatitis C virus antibody (anti-HCV); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Rubella IgG antibody; Syphilis Treponema pallidum antibody | ||
| Serum | Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag) | |
| Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mycoplasma pneumoniae IgG antibody; Mycoplasma pneumoniae IgM antibody; Parvovirus B19 IgG antibody; Parvovirus B19 IgM antibody; Varicella zoster virus (VZV) IgG antibody | ||
| Helicobacter pylori IgG antibody; Rubella IgM antibody; Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody | ||
| Dengue virus IgG antibody; Dengue virus IgM antibody; Dengue virus NS1 antigen | ||
| Echinococcus granulosus total antibody | ||
| Streptococcal anti-DNAse B (anti-streptodornase) antibody | ||
| Entamoeba histolytica | ||
| Diphtheriae toxoid IgG antibody; Haemophilus influenzae type B IgG antibody; Tetanus IgG antibody | ||
| Anti-streptolysin O (ASOT) | ||
| Syphilis Treponema pallidum antibody |
Intensive Care Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Microbiology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Bacterial isolates; Biopsy specimens; Blood; Bronchoalveolar lavage; Bronchoalveolar washings; Cerebrospinal fluid (CSF); Cervical swabs; Dry swabs; Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; Genital swabs; Human breast milk; IV catheters; Infusates; Intra-uterine contraceptive device (IUCD); Isolates; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Ocular specimens; Operative specimens; Oral sites; Post-operative wounds; Pus; Respiratory specimens; Skin; Skin swabs; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urethra; Urine; Vaginal swabs; Wound swabs | Bacteria; Pathogenic identification; Pathogenic microorganisms |
| Aspirates; Bacterial isolates; Biopsy specimens; Blood; Bronchoalveolar lavage; Bronchoalveolar washings; Cerebrospinal fluid (CSF); Cervical swabs; Dry swabs; Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; Genital swabs; Human breast milk; IV catheters; Infusates; Intra-uterine contraceptive device (IUCD); Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Ocular specimens; Operative specimens; Oral sites; Post-operative wounds; Pus; Respiratory specimens; Skin; Skin swabs; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urethra; Urine; Vaginal swabs; Wound swabs | Bacteria; Pathogenic microorganisms | |
| Antibiotic susceptibility; Bacteria; Pathogenic microorganisms | ||
| Aspirates; Bacterial isolates; Biopsy specimens; Bronchoalveolar lavage; Bronchoalveolar washings; Cerebrospinal fluid (CSF); Cervical swabs; Dry swabs; Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; Genital specimens; Human breast milk; IV catheters; Infusates; Intra-uterine contraceptive device (IUCD); Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Ocular specimens; Operative specimens; Oral sites; Post-operative wounds; Pus; Respiratory specimens; Skin; Skin swabs; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urethra; Urine; Vaginal swabs; Wound swabs | Antibiotic susceptibility; Bacteria; Pathogenic microorganisms | |
| Aspirates; Biopsy specimens; Blood; Bronchoalveolar lavage; Bronchoalveolar washings; Cerebrospinal fluid (CSF); Cervical swabs; Dry swabs; Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; Genital swabs; Human breast milk; Infusates; Nasopharyngeal aspirate; Nasopharyngeal swabs; Ocular specimens; Operative specimens; Oral sites; Post-operative wounds; Pus; Red cell concentrates; Respiratory specimens; Skin; Skin swabs; Sputum; Stem cells; Superficial sites; Synovial fluid; Tissues; Urethra; Urine; Vaginal swabs; Wound swabs | Bacteria; Casts; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Urinary sediment | |
| Blood | Bacteria; Pathogenic microorganisms | |
| Faeces | Clostridioides difficile toxin | |
| Helicobacter pylori antigen | ||
| Urine | Blood; Glucose; Leucocytes (white blood cells, WBC); Nitrite; Proteins; pH | |
| Legionella antigen; Streptococcus pneumoniae antigen | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Faeces; Groin swabs; Infection control swabs; Nasal swabs; Perianal swabs; Rectal swabs | Carbapenem resistant Enterobacteriaceae (CRE); Extended spectrum beta-lactamases (ESBL); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) |
| Carbapenem resistant Enterobacteriaceae (CRE); Extended spectrum beta-lactamases (ESBL); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Air | Bacterial growth - Sterility; Mycology identification |
| Blood transfusion bags; Endoscopes; Vascular catheter tips | Bacterial growth - Sterility; Mycology identification | |
| Implanted prostheses | Bacterial growth - Sterility | |
| Spore strips | Bacterial growth - Sterility | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | Enterobacteriaceae resistant gene IMP-1; Enterobacteriaceae resistant gene KPC-2; Enterobacteriaceae resistant gene NDM-1; Enterobacteriaceae resistant gene OXA-48; Enterobacteriaceae resistant gene VIM-1 |
| MecA/nuc gene | ||
| Bacterial isolates; Blood | Van A/B | |
| Cerebrospinal fluid (CSF) | Haemophilus influenzae; Listeria monocytogenes; Neisseria meningitidis; Streptococcus agalactiae (Streptococcus group B); Streptococcus pneumoniae | |
| Faeces | Clostridioides difficile toxin | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Cerebrospinal fluid (CSF) | Cryptococcus gattii; Cryptococcus neoformans |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Bacterial isolates; Sputum | Mycobacterium tuberculosis complex; Mycobacterium rifampicin resistance rpoB |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Cerebrospinal fluid (CSF) | Cytomegalovirus (CMV); Enterovirus; Herpes simplex virus (HSV); Human herpes virus type 6 (HHV6); Human parechovirus; Varicella zoster virus (VZV) |
| Dry swabs; Nasopharyngeal aspirate | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Faeces | Norovirus | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Isolates | Mycobacteria antibiotic susceptibility |
| Sputum; Tissues; Urine | Mycobacteria detection | |
| Mycobacteria detection | ||
| Mycobacteria detection | ||
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Hair; Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Aspirates; Blood; Bronchial lavage; Bronchial washings; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fine needle aspirates (FNA); Fluids; General swabs; Genital swabs; Hair; IV catheters; Isolates; Nails; Nasal swabs; Ocular specimens; Operative specimens; Oral sites; Peritoneal fluid; Pleural fluid; Post-operative wounds; Pus; Respiratory specimens; Skin; Skin scrapings; Skin swabs; Sputum; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Fungi identification; Yeasts identification |
| Cerebrospinal fluid (CSF) | Cryptococcus antigen | |
| Cerebrospinal fluid (CSF); Fluids; Synovial fluid | Fungi identification; Yeasts identification | |
| Hair; Nails; Skin scrapings | Fungi identification; Yeasts identification | |
| Isolates | Fungi identification; Fungi susceptibility; Yeast susceptibility; Yeasts identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cryptosporidia; Giardia spp. |
| Cysts; Ova; Parasites | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Adenovirus; Rotavirus |
Molecular Pathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Blood; Cerebrospinal fluid (CSF) | Neisseria meningitidis |
| Bronchoalveolar lavage; Sputum | Bordetella pertussis; Chlamydophila pneumoniae; Chlamydophila psittaci; Legionella longbeachae; Legionella pneumophila; Mycoplasma pneumoniae | |
| Dry swabs; Genital swabs | Mycoplasma genitalium; Trichomonas vaginalis; Macrolide resistant Mycoplasma genitalium | |
| Dry swabs; Nasopharyngeal aspirate | Bordetella pertussis; Mycoplasma pneumoniae | |
| Dry swabs; Urine | Chlamydia trachomatis | |
| Neisseria gonorrhoeae | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Bronchoalveolar lavage; Plasma | Pneumocystis jirovecii |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Aspirates; Blood; Cell culture; Cerebrospinal fluid (CSF); Dry swabs; Fluids; General swabs; Plasma; Serum; Urine | Adenovirus; Cytomegalovirus (CMV); Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) |
| Blood; Dry swabs; Plasma; Serum; Urine | Cytomegalovirus (CMV) | |
| Bronchial washings; Nasal aspirates/washes; Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Adenovirus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Cerebrospinal fluid (CSF); Plasma; Serum | Enterovirus | |
| Dry swabs | Monkeypox virus | |
| Dry swabs; Nasopharyngeal aspirate | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| General swabs; Serum; Urine | Measles virus | |
| Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Nasal aspirates/washes; Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasal aspirates/washes; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Plasma; Serum | Hepatitis C virus (HCV) viral load - Qualitative | |
| Microbiology - Molecular biology - Microbial genotyping | Plasma; Serum | Hepatitis C virus (HCV) subtypes |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma | Human immunodeficiency virus (HIV) RNA viral load |
| Plasma; Serum | Hepatitis B virus (HBV) viral load |
Neonatal Intensive Care Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Operating Theatres
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Paediatric Diabetic Clinic
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Post Operative Acute Care Unit (PACU)
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Respiratory Sleep Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
06 Jul 2027
Last Activity Date
25 Apr 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2508
Site No.
2501
Print date
24 Nov 2024
END OF SCOPE